{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:39:30Z","timestamp":1790635170917,"version":"4.1.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T00:00:00Z","timestamp":1370908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s40272-013-0031-7","type":"journal-article","created":{"date-parts":[[2013,6,10]],"date-time":"2013-06-10T12:05:45Z","timestamp":1370865945000},"page":"363-376","source":"Crossref","is-referenced-by-count":34,"title":["Clinical Pharmacology of Indomethacin in Preterm Infants: Implications in Patent Ductus Arteriosus Closure"],"prefix":"10.1007","volume":"15","author":[{"given":"Gian Maria","family":"Pacifici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,11]]},"reference":[{"key":"31_CR1","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/FTD.0b013e31815b3e13","volume":"29","author":"M Al Za\u2019abi","year":"2007","unstructured":"Al Za\u2019abi M, Donovan T, Tudehope D, et al. Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome. Ther Drug Monit. 2007;29:807\u201314.","journal-title":"Ther Drug Monit"},{"key":"31_CR2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/adc.65.1_Spec_No.24","volume":"65","author":"NJ Evans","year":"1990","unstructured":"Evans NJ, Archer LN. Postnatal circulatory adaptation in healthy term and preterm neonates. Arch Dis Child. 1990;65:24\u20136.","journal-title":"Arch Dis Child"},{"key":"31_CR3","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0022-3476(84)80499-0","volume":"104","author":"GG Dudell","year":"1984","unstructured":"Dudell GG, Gersony WM. Patent ductus arteriosus in neonates with severe respiratory disease. J Pediatr. 1984;104:915\u201320.","journal-title":"J Pediatr"},{"key":"31_CR4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1440-1754.1991.tb00422.x","volume":"27","author":"VS Rajadurai","year":"1991","unstructured":"Rajadurai VS, Yu VY. Intravenous indomethacin therapy in preterm neonates with patent ductus arteriosus. J Paediatr Child Health. 1991;27:370\u20135.","journal-title":"J Paediatr Child Health"},{"key":"31_CR5","first-page":"e215","volume":"4","author":"M Narayan","year":"2003","unstructured":"Narayan M, Clyman R. Pharmacologic closure of patent ductus arteriosus in the neonate. Neo Rev. 2003;4:e215\u201322.","journal-title":"Neo Rev"},{"key":"31_CR6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJM197609022951003","volume":"295","author":"WF Friedman","year":"1976","unstructured":"Friedman WF, Hirschklau MJ, Printz MP, et al. Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med. 1976;295:526\u20139.","journal-title":"N Engl J Med"},{"key":"31_CR7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0065-3101(22)00692-2","volume":"25","author":"WF Friedman","year":"1978","unstructured":"Friedman WF, Molony DA, Kirkpatrick SE. Prostaglandins: physiological and clinical correlations. Adv Pediatr. 1978;25:151\u2013204.","journal-title":"Adv Pediatr"},{"key":"31_CR8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0090-6980(75)90034-9","volume":"9","author":"F Coceani","year":"1975","unstructured":"Coceani F, Olley PM, Bodach E. Lamb ductus arteriosus: effect of prostaglandin synthesis inhibitors on the muscle tone and the response to prostaglandin E2. Prostaglandins. 1975;9:299\u2013308.","journal-title":"Prostaglandins"},{"key":"31_CR9","doi-asserted-by":"crossref","unstructured":"Herrera C, Holberton J, Davis P. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2007;(2):CD003480.","DOI":"10.1002\/14651858.CD003480.pub3"},{"key":"31_CR10","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/jp.2008.109","volume":"28","author":"WF Malcolm","year":"2008","unstructured":"Malcolm WF, Hornik C, Evans A, et al. Vocal fold paralysis following surgical ductal closure in extremely low birth weight infants: a case series of feeding and respiratory complications. J Perinatol. 2008;28:782\u20135.","journal-title":"J Perinatol"},{"key":"31_CR11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1542\/peds.2006-3124","volume":"119","author":"N Chorne","year":"2007","unstructured":"Chorne N, Leonard C, Piecuch R, et al. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics. 2007;119:1165\u201374.","journal-title":"Pediatrics"},{"key":"31_CR12","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0022-3476(83)80022-5","volume":"102","author":"WM Gersony","year":"1983","unstructured":"Gersony WM, Peckham GJ, Ellison RC, et al. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr. 1983;102:895\u2013906.","journal-title":"J Pediatr"},{"key":"31_CR13","first-page":"38","volume":"33","author":"JM Ramsay","year":"1987","unstructured":"Ramsay JM, Murphy DJ Jr, Vick GW 3rd. Response of the patent ductus arteriosus to indomethacin treatment. Am J Dis Child. 1987;141:294\u20137. J Paediatr Child Health. 1987;33:38\u201341.","journal-title":"J Paediatr Child Health"},{"key":"31_CR14","unstructured":"Young TE, Mangum B. Cardiovascular. In: Neofax: a manual of drugs used in neonatal care. 23rd ed. Montvale: Thomson Reuters; 2010. p. 180\u20131."},{"key":"31_CR15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000457690","volume":"11","author":"SM Douidar","year":"1988","unstructured":"Douidar SM, Richardson J, Snodgrass WR. Role of indomethacin in ductus closure: an update evaluation. Dev Pharmacol Ther. 1988;11:196\u2013212.","journal-title":"Dev Pharmacol Ther"},{"issue":"1 Pt 1","key":"31_CR16","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1542\/peds.110.1.e10","volume":"110","author":"D Quinn","year":"2002","unstructured":"Quinn D, Cooper B, Clyman RI. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy. Pediatrics. 2002;110(1 Pt 1):e10.","journal-title":"Pediatrics"},{"key":"31_CR17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1203\/00006450-197204000-00004","volume":"6","author":"DM McMurphy","year":"1972","unstructured":"McMurphy DM, Heymann MA, Rudolph AM, et al. Developmental changes in constriction of the ductus arteriosus: responses to oxygen and vasoactive agents in the isolated ductus arteriosus of the fetal lamb. Pediatr Res. 1972;6:231\u20138.","journal-title":"Pediatr Res"},{"key":"31_CR18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-4615-9035-4_9","volume":"78","author":"FS Fay","year":"1977","unstructured":"Fay FS, Nair P, Whalen WJ. Mechanism of oxygen induced contraction of ductus arteriosus. Adv Exp Med Biol. 1977;78:123\u201334.","journal-title":"Adv Exp Med Biol"},{"key":"31_CR19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0090-6980(75)90064-7","volume":"9","author":"GL Sharpe","year":"1975","unstructured":"Sharpe GL, Larsson KS, Thalme B. Studies on closure of the ductus arteriosus: XII. In utero effect of indomethacin and sodium salicylate in rats and rabbits. Prostaglandins. 1975;9:585\u201396.","journal-title":"Prostaglandins"},{"key":"31_CR20","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJM197609022951004","volume":"295","author":"MA Heymann","year":"1976","unstructured":"Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med. 1976;295:530\u20133.","journal-title":"N Engl J Med"},{"key":"31_CR21","doi-asserted-by":"crossref","unstructured":"Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and\/or low birth weight infants. Cochrane Database Syst Rev. 2005;(4):CD003481.","DOI":"10.1002\/14651858.CD003481.pub2"},{"key":"31_CR22","doi-asserted-by":"crossref","unstructured":"Thomas RL, Parker GC, Van Overmeire B, et al. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr. 2005;164:135\u201340 (review).","DOI":"10.1007\/s00431-004-1596-5"},{"key":"31_CR23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000455528","volume":"1","author":"R Bhat","year":"1980","unstructured":"Bhat R, Vidyasagar D, Fisher E, et al. Pharmacokinetics of oral and intravenous indomethacin in preterm infants. Dev Pharmacol Ther. 1980;1:101\u201310.","journal-title":"Dev Pharmacol Ther"},{"key":"31_CR24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1056\/NEJM198107093050203","volume":"305","author":"AR Brash","year":"1981","unstructured":"Brash AR, Hickey DE, Graham TP, et al. Pharmacokinetics of indomethacin in the neonate. Relation of plasma indomethacin levels to response of the ductus arteriosus. N Engl J Med. 1981;305:67\u201372.","journal-title":"N Engl J Med"},{"key":"31_CR25","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1542\/peds.2005-0293","volume":"116","author":"M Sperandio","year":"2005","unstructured":"Sperandio M, Beedgen B, Feneberg R, et al. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33\u00a0weeks of gestation. Pediatrics. 2005;116:1361\u20136.","journal-title":"Pediatrics"},{"key":"31_CR26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00003246-200202000-00013","volume":"30","author":"CL Shaffer","year":"2002","unstructured":"Shaffer CL, Gal P, Ransom JL, et al. Effect of age and birth weight on indomethacin pharmacodynamics in neonates treated for patent ductus arteriosus. Crit Care Med. 2002;30:343\u20138.","journal-title":"Crit Care Med"},{"key":"31_CR27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1440-1754.1997.tb00988.x","volume":"33","author":"RK Kumar","year":"1997","unstructured":"Kumar RK, Yu VY. Prolonged low-dose indomethacin therapy for patent ductus arteriosus in very low birthweight infants. J Paediatr Child Health. 1997;33:38\u201341.","journal-title":"J Paediatr Child Health"},{"issue":"1\u20132","key":"31_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000457493","volume":"17","author":"CA Friedman","year":"1991","unstructured":"Friedman CA, Temple DM, Wender DF, et al. Metabolism and disposition of indomethacin in preterm infants. Dev Pharmacol Ther. 1991;17(1\u20132):1\u20137.","journal-title":"Dev Pharmacol Ther"},{"key":"31_CR29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00003088-198106040-00001","volume":"6","author":"L Helleberg","year":"1981","unstructured":"Helleberg L. Clinical Pharmacokinetics of indomethacin. Clin Pharmacokinet. 1981;6:245\u201358.","journal-title":"Clin Pharmacokinet"},{"key":"31_CR30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0022-3476(79)80683-6","volume":"95","author":"R Bhat","year":"1979","unstructured":"Bhat R, Vidyasagar D, Vadapalli M, et al. Disposition of indomethacin in preterm infants. J Pediatr. 1979;95:313\u20136.","journal-title":"J Pediatr"},{"key":"31_CR31","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0022-3476(80)80446-X","volume":"97","author":"SJ Yaffe","year":"1980","unstructured":"Yaffe SJ, Friedman WF, Rogers D, et al. The disposition of indomethacin in preterm babies. J Pediatr. 1980;97:1001\u20136.","journal-title":"J Pediatr"},{"key":"31_CR32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000455529","volume":"1","author":"G Bianchetti","year":"1980","unstructured":"Bianchetti G, Monin P, Marchal F, et al. Pharmacokinetics of indomethacin in the premature infant. Dev Pharmacol Ther. 1980;1:111\u201324.","journal-title":"Dev Pharmacol Ther"},{"key":"31_CR33","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/cpt1975183364","volume":"18","author":"G Alv\u00e1n","year":"1975","unstructured":"Alv\u00e1n G, Orme M, Bertilsson L, et al. Pharmacokinetics of indomethacin. Clin Pharmacol Ther. 1975;18:364\u201373.","journal-title":"Clin Pharmacol Ther"},{"key":"31_CR34","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0022-3476(80)80445-8","volume":"97","author":"AA Thalji","year":"1980","unstructured":"Thalji AA, Carr I, Yeh TF, et al. Pharmacokinetics of intravenously administered indomethacin in premature infants. J Pediatr. 1980;97:995\u20131000.","journal-title":"J Pediatr"},{"key":"31_CR35","first-page":"F529","volume":"232","author":"T Berl","year":"1977","unstructured":"Berl T, Raz A, Wald H, et al. Prostaglandin synthesis inhibition and the action of vasopressin: studies in man and rat. Am J Physiol. 1977;232:F529\u201337.","journal-title":"Am J Physiol"},{"key":"31_CR36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1542\/peds.64.2.154","volume":"64","author":"HL Halliday","year":"1979","unstructured":"Halliday HL, Hirata T, Brady JP. Indomethacin therapy for large patent ductus arteriosus in the very low birth weight infant: results and complications. Pediatrics. 1979;64:154\u20139.","journal-title":"Pediatrics"},{"key":"31_CR37","first-page":"251","volume":"1","author":"M Evans","year":"1981","unstructured":"Evans M, Bhat R, Vidyasagar D, et al. A comparison of oral and intravenous indomethacin dispositions in the premature infant with patent ductus arteriosus. Pediatr Pharmacol (New York). 1981;1:251\u20138.","journal-title":"Pediatr Pharmacol (New York)"},{"key":"31_CR38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-2004-828612","volume":"21","author":"DJ O\u2019Donovan","year":"2004","unstructured":"O\u2019Donovan DJ, Fernandes CJ, Nguyen NY, et al. Indomethacin therapy for patent ductus arteriosus in premature infants: efficacy of a dosing strategy based on a second-dose peak plasma indomethacin level and estimated plasma indomethacin levels. Am J Perinatol. 2004;21:191\u20137.","journal-title":"Am J Perinatol"},{"key":"31_CR39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00007691-199101000-00005","volume":"13","author":"P Gal","year":"1991","unstructured":"Gal P, Ransom JL, Weaver RL, et al. Indomethacin pharmacokinetics in neonates: the value of volume of distribution as a marker of permanent patent ductus arteriosus closure. Ther Drug Monit. 1991;13:42\u20135.","journal-title":"Ther Drug Monit"},{"key":"31_CR40","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/BF01995866","volume":"149","author":"M Weninger","year":"1989","unstructured":"Weninger M, Pollak A, Salzer-Muhar U, et al. Pharmacokinetics of intra-arterial indomethacin treatment for patent ductus arteriosus. Eur J Pediatr. 1989;149:138\u201340.","journal-title":"Eur J Pediatr"},{"key":"31_CR41","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/clpt.1991.65","volume":"49","author":"DB Wiest","year":"1991","unstructured":"Wiest DB, Pinson JB, Gal PS, et al. Population pharmacokinetics of intravenous indomethacin in neonates with symptomatic patent ductus arteriosus. Clin Pharmacol Ther. 1991;49:550\u20137.","journal-title":"Clin Pharmacol Ther"},{"key":"31_CR42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2125.2004.02139.x","volume":"58","author":"JM Smyth","year":"2004","unstructured":"Smyth JM, Collier PS, Darwish M, et al. Intravenous indometacin in preterm infants with symptomatic patent ductus arteriosus: a population pharmacokinetic study. Br J Clin Pharmacol. 2004;58:249\u201358.","journal-title":"Br J Clin Pharmacol"},{"key":"31_CR43","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1442-200X.2009.02977.x","volume":"52","author":"S Yoshimoto","year":"2010","unstructured":"Yoshimoto S, Sakai H, Ueda M, et al. Prophylactic indomethacin in extremely premature infants between 23 and 24\u00a0weeks gestation. Pediatr Int. 2010;52:374\u20137.","journal-title":"Pediatr Int"},{"key":"31_CR44","doi-asserted-by":"crossref","unstructured":"Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev. 2010;(7):CD000174.","DOI":"10.1002\/14651858.CD000174.pub2"},{"key":"31_CR45","doi-asserted-by":"crossref","first-page":"F464","DOI":"10.1136\/fn.88.6.F464","volume":"88","author":"PW Fowlie","year":"2003","unstructured":"Fowlie PW, Davis PG. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2003;88:F464\u20136.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"31_CR46","doi-asserted-by":"crossref","unstructured":"Cooke L, Steer P, Woodgate P. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2003;(2):CD003745.","DOI":"10.1002\/14651858.CD003745"},{"key":"31_CR47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/hrt.41.3.304","volume":"41","author":"HH Ivey","year":"1979","unstructured":"Ivey HH, Kattwinkel J, Park TS, et al. Failure of indomethacin to close persistent ductus arteriosus in infants weighing under 1000 grams. Br Heart J. 1979;41:304\u20137.","journal-title":"Br Heart J"},{"key":"31_CR48","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/adc.55.4.271","volume":"55","author":"HI Obeyesekere","year":"1980","unstructured":"Obeyesekere HI, Pankhurst S, Yu VY. Pharmacological closure of ductus arteriosus in preterm infants using indomethacin. Arch Dis Child. 1980;55:271\u20136.","journal-title":"Arch Dis Child"},{"key":"31_CR49","first-page":"250","volume":"9","author":"B Achanti","year":"1986","unstructured":"Achanti B, Yeh TF, Pildes RS. Indomethacin therapy in infants with advanced postnatal age and patent ductus arteriosus. Clin Invest Med. 1986;9:250\u20133.","journal-title":"Clin Invest Med"},{"key":"31_CR50","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJM198303313081303","volume":"308","author":"TP Green","year":"1983","unstructured":"Green TP, Thompson TR, Johnson DE, et al. Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome. N Engl J Med. 1983;308:743\u20138.","journal-title":"N Engl J Med"},{"key":"31_CR51","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0022-3476(82)80079-6","volume":"101","author":"TF Yeh","year":"1982","unstructured":"Yeh TF, Wilks A, Singh J, et al. Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus. J Pediatr. 1982;101:433\u20137.","journal-title":"J Pediatr"},{"key":"31_CR52","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1651-2227.2009.01224.x","volume":"98","author":"P Andriessen","year":"2009","unstructured":"Andriessen P, Struis NC, Niemarkt H, et al. Furosemide in preterm infants treated with indomethacin for patent ductus arteriosus. Acta Paediatr. 2009;98:797\u2013803.","journal-title":"Acta Paediatr"},{"key":"31_CR53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1542\/peds.112.2.345","volume":"112","author":"J Lee","year":"2003","unstructured":"Lee J, Rajadurai VS, Tan KW, Wong KY, et al. Randomized trial of prolonged low-dose versus conventional-dose indomethacin for treating patent ductus arteriosus in very low birth weight infants. Pediatrics. 2003;112:345\u201350.","journal-title":"Pediatrics"},{"key":"31_CR54","first-page":"164","volume":"117","author":"PK Sharma","year":"2003","unstructured":"Sharma PK, Garg SK, Narang A. A preliminary study on pharmacokinetics of oral indomethacin in premature infants in north India. Indian J Med Res. 2003;117:164\u20139.","journal-title":"Indian J Med Res"},{"key":"31_CR55","doi-asserted-by":"crossref","unstructured":"G\u00f6rk AS, Ehrenkranz RA, Bracken MB. Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants. Cochrane Database Syst Rev. 2008;(1):CD006071.","DOI":"10.1002\/14651858.CD006071.pub2"},{"key":"31_CR56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-2005-837273","volume":"22","author":"NK Vries de","year":"2005","unstructured":"de Vries NK, Jagroep FK, Jaarsma AS, et al. Continuous indomethacin infusion may be less effective than bolus infusions for ductal closure in very low birth weight infants. Am J Perinatol. 2005;22:71\u20135.","journal-title":"Am J Perinatol"},{"key":"31_CR57","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1542\/peds.95.2.244","volume":"95","author":"C Hammerman","year":"1995","unstructured":"Hammerman C, Glaser J, Schimmel MS, et al. Continuous versus multiple rapid infusions of indomethacin: effects on cerebral blood flow velocity. Pediatrics. 1995;95:244\u20138.","journal-title":"Pediatrics"},{"key":"31_CR58","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1526-4610.2010.01803.x","volume":"51","author":"G Lambru","year":"2011","unstructured":"Lambru G, Manzoni GC, Torelli P, et al. Reversible cerebral vasoconstriction phenomena following indomethacin administration. Headache. 2011;51:813\u20138.","journal-title":"Headache"},{"key":"31_CR59","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1651-2227.2002.tb01668.x","volume":"91","author":"V Christmann","year":"2002","unstructured":"Christmann V, Liem KD, Semmekrot BA, et al. Changes in cerebral, renal and mesenteric blood flow velocity during continuous and bolus infusion of indomethacin. Acta Paediatr. 2002;91:440\u20136.","journal-title":"Acta Paediatr"},{"key":"31_CR60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/01.CIR.71.1.141","volume":"71","author":"RI Clyman","year":"1985","unstructured":"Clyman RI, Campbell D, Heymann MA, et al. Persistent responsiveness of the neonatal ductus arteriosus in immature lambs: a possible cause for reopening of patent ductus arteriosus after indomethacin-induced closure. Circulation. 1985;71:141\u20135.","journal-title":"Circulation"},{"key":"31_CR61","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0022-3476(99)70239-8","volume":"134","author":"O Tammela","year":"1999","unstructured":"Tammela O, Ojala R, Iivainen T, et al. Short versus prolonged indomethacin therapy for patent ductus arteriosus in preterm infants. J Pediatr. 1999;134:552\u20137.","journal-title":"J Pediatr"},{"key":"31_CR62","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/adc.66.1_Spec_No.55","volume":"66","author":"JM Rennie","year":"1991","unstructured":"Rennie JM, Cooke RW. Prolonged low dose indomethacin for persistent ductus arteriosus of prematurity. Arch Dis Child. 1991;66:55\u20138.","journal-title":"Arch Dis Child"},{"key":"31_CR63","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00246-009-9628-6","volume":"31","author":"C McPherson","year":"2010","unstructured":"McPherson C, Gal P, Ransom JL, et al. Indomethacin pharmacodynamics are altered by surfactant: a possible challenge to current indomethacin dosing guidelines created before surfactant availability. Pediatr Cardiol. 2010;31:505\u201310.","journal-title":"Pediatr Cardiol"},{"key":"31_CR64","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.jp.7210698","volume":"22","author":"I Seri","year":"2002","unstructured":"Seri I, Abbasi S, Wood DC, et al. Regional hemodynamic effects of dopamine in the indomethacin-treated preterm infant. J Perinatol. 2002;22:300\u20135.","journal-title":"J Perinatol"},{"key":"31_CR65","doi-asserted-by":"crossref","unstructured":"Barrington K, Brion LP. Dopamine versus no treatment to prevent renal dysfunction in indomethacin-treated preterm newborn infants. Cochrane Database Syst Rev. 2002;(3):CD003213.","DOI":"10.1002\/14651858.CD003213"},{"issue":"5 Pt 1","key":"31_CR66","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0022-3476(05)81914-6","volume":"121","author":"CA Fajardo","year":"1992","unstructured":"Fajardo CA, Whyte RK, Steele BT. Effect of dopamine on failure of indomethacin to close the patent ductus arteriosus. J Pediatr. 1992;121(5 Pt 1):771\u20135.","journal-title":"J Pediatr"},{"key":"31_CR67","first-page":"209","volume":"5","author":"I Seri","year":"1984","unstructured":"Seri I, Tulassay T, Kiszel J, et al. The use of dopamine for the prevention of the renal side effects of indomethacin in premature infants with patent ductus arteriosus. Int J Pediatr Nephrol. 1984;5:209\u201314.","journal-title":"Int J Pediatr Nephrol"},{"key":"31_CR68","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1203\/00006450-198811000-00021","volume":"24","author":"AJ vd Heijden","year":"1988","unstructured":"vd Heijden AJ, Provoost AP, Nauta J, et al. Renal functional impairment in preterm neonates related to intrauterine indomethacin exposure. Pediatr Res. 1988;24:644\u20138.","journal-title":"Pediatr Res"},{"key":"31_CR69","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1067\/mob.2002.127464","volume":"187","author":"VR Suarez","year":"2002","unstructured":"Suarez VR, Thompson LL, Jain V, et al. The effect of in utero exposure to indomethacin on the need for surgical closure of a patent ductus arteriosus in the neonate. Am J Obstet Gynecol. 2002;187:886\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"31_CR70","doi-asserted-by":"crossref","first-page":"E56","DOI":"10.1542\/peds.102.5.e56","volume":"102","author":"C Hammerman","year":"1998","unstructured":"Hammerman C, Glaser J, Kaplan M, et al. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity. Pediatrics. 1998;102:E56.","journal-title":"Pediatrics"},{"key":"31_CR71","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1701-2163(16)34496-6","volume":"32","author":"AS Soraisham","year":"2010","unstructured":"Soraisham AS, Dalgleish S, Singhal N. Antenatal indomethacin tocolysis is associated with an increased need for surgical ligation of patent ductus arteriosus in preterm infants. J Obstet Gynaecol Can. 2010;32:435\u201342.","journal-title":"J Obstet Gynaecol Can"},{"key":"31_CR72","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1067\/S0002-9378(03)00662-8","volume":"189","author":"S Abbasi","year":"2003","unstructured":"Abbasi S, Gerdes JS, Sehdev HM, et al. Neonatal outcome after exposure to indomethacin in utero: a retrospective case cohort study. Am J Obstet Gynecol. 2003;189:782\u20135.","journal-title":"Am J Obstet Gynecol"},{"key":"31_CR73","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1542\/peds.2011-0265","volume":"128","author":"BG Sood","year":"2011","unstructured":"Sood BG, Lulic-Botica M, Holzhausen KA, et al. The risk of necrotizing enterocolitis after indomethacin tocolysis. Pediatrics. 2011;128:e54\u201362.","journal-title":"Pediatrics"},{"issue":"Suppl 3","key":"31_CR74","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/14767050903180965","volume":"22","author":"K Allegaert","year":"2009","unstructured":"Allegaert K. The impact of ibuprofen or indomethacin on renal drug clearance in neonates. J Matern Fetal Neonatal Med. 2009;22(Suppl 3):88\u201391.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"31_CR75","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1136\/adc.66.10.1261","volume":"66","author":"RC Coombs","year":"1991","unstructured":"Coombs RC, Morgan ME, Durbin GM, et al. Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indomethacin. Arch Dis Child. 1991;66:1261.","journal-title":"Arch Dis Child"},{"key":"31_CR76","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000327844","volume":"101","author":"A Sehgal","year":"2012","unstructured":"Sehgal A, Ramsden CA, McNamara PJ. Indomethacin impairs coronary perfusion in infants with hemodynamically significant ductus arteriosus. Neonatology. 2012;101:20\u20137.","journal-title":"Neonatology"},{"key":"31_CR77","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s00467-011-1883-0","volume":"26","author":"I George","year":"2011","unstructured":"George I, Mekahli D, Rayyan M, et al. Postnatal trends in creatinemia and its covariates in extremely low birth weight (ELBW) neonates. Pediatr Nephrol. 2011;26:1843\u20139.","journal-title":"Pediatr Nephrol"},{"key":"31_CR78","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1472-8206.2004.00314.x","volume":"19","author":"V Fanos","year":"2005","unstructured":"Fanos V, Benini D, Verlato G, et al. Efficacy and renal tolerability of ibuprofen vs. indomethacin in preterm infants with patent ductus arteriosus. Fundam Clin Pharmacol. 2005;19:187\u201393.","journal-title":"Fundam Clin Pharmacol"},{"key":"31_CR79","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/sper.2002.37310","volume":"26","author":"JP Guignard","year":"2002","unstructured":"Guignard JP. The adverse renal effects of prostaglandin-synthesis inhibitors in the newborn rabbit. Semin Perinatol. 2002;26:398\u2013405.","journal-title":"Semin Perinatol"},{"key":"31_CR80","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000289206","volume":"98","author":"BS Lee","year":"2010","unstructured":"Lee BS, Byun SY, Chung ML, Chang JY, et al. Effect of furosemide on ductal closure and renal function in indomethacin-treated preterm infants during the early neonatal period. Neonatology. 2010;98:191\u20139.","journal-title":"Neonatology"},{"key":"31_CR81","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/15513810600908354","volume":"25","author":"BM Shehata","year":"2006","unstructured":"Shehata BM, Bare JB, Denton TD, et al. Premature closure of the ductus arteriosus: variable response among monozygotic twins after in utero exposure to indomethacin. Fetal Pediatr Pathol. 2006;25:151\u20137.","journal-title":"Fetal Pediatr Pathol"},{"key":"31_CR82","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.semperi.2011.09.019","volume":"36","author":"H Hajj","year":"2012","unstructured":"Hajj H, Dagle JM. Genetics of patent ductus arteriosus susceptibility and treatment. Semin Perinatol. 2012;36:98\u2013104.","journal-title":"Semin Perinatol"},{"key":"31_CR83","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000262481","volume":"98","author":"R B\u00f6kenkamp","year":"2010","unstructured":"B\u00f6kenkamp R, DeRuiter MC, van Munsteren C, et al. Insights into the pathogenesis and genetic background of patency of the ductus arteriosus. Neonatology. 2010;98:6\u201317.","journal-title":"Neonatology"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-013-0031-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-013-0031-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-013-0031-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T08:57:17Z","timestamp":1688288237000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-013-0031-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,11]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["31"],"URL":"https:\/\/doi.org\/10.1007\/s40272-013-0031-7","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,11]]}}}